1 Introduction Head and neck squamous cell carcinoma (HNSCC) represents a global health burden as the seventh most common cancer worldwide [1]. Patient outcomes vary significantly based on human papillomavirus (HPV) status, with 5-year overall survival rates of 50% and 80% for HPV-negative disease and HPV-positive disease, respectively. Disease recurrence, distant metastases, and second primary tumors confer a poor prognosis [2, 3].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Blenheim
Contact Blenheim, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack